e-space
Manchester Metropolitan University's Research Repository

    The role of frequent engagement in alliances in firm likelihood to patent: first wave alliances in UK bio-pharmaceuticals

    Filiou, Despoina ORCID logoORCID: https://orcid.org/0000-0001-5521-0310, Tuselmann, Heinz ORCID logoORCID: https://orcid.org/0000-0001-6628-1675 and Green, Lawrence ORCID logoORCID: https://orcid.org/0000-0002-9781-8700 (2020) The role of frequent engagement in alliances in firm likelihood to patent: first wave alliances in UK bio-pharmaceuticals. European Journal of Innovation Management, 23 (5). pp. 919-938. ISSN 1460-1060

    [img]
    Preview
    Accepted Version
    Available under License Creative Commons Attribution Non-commercial.

    Download (294kB) | Preview

    Abstract

    Purpose This article explores the role of alliance experience in firm innovation; it argues that, while cumulative alliance experience has a marginally diminishing contribution to likelihood of firm innovation over time, frequent engagement in alliances and an expanding alliance portfolio inhabit an enhancing role. This reveals new dimensions to the role of alliance experience as an antecedent to firm learning in managing alliances and to the development of alliance capabilities. Design/methodology/approach The paper estimates a range of models identifying the relationship between alliance experience and firm innovation. The panel data sample captures the full range of firms active in the UK bio-pharmaceuticals sector during the early stages of its development, observing them from 1991 to 2001. An exploratory case study analysis is employed to shed light on the nuanced factors linking frequent engagement in alliances to the development of practices for efficient alliance management. Findings The paper shows that cumulative alliance experience has a marginally diminishing contribution to likelihood of firm innovation over time, while frequent engagement in alliances and the ensuing expansion of alliance portfolios, enhance firm innovation. The exploratory case analysis demonstrates a link between frequent engagement in alliances and the development of processes for alliance management that could collectively reflect alliance capabilities. Originality/value Our contribution derives from a longitudinal analysis of an original panel dataset that maps the UK bio-pharmaceuticals sector over the initial period of its development. The paper (a) sheds light on factors that can impel firms to form alliance capabilities, and (b) extends a currently thin body of work on the foundations and antecedents to alliance and alliance portfolio capabilities.

    Impact and Reach

    Statistics

    Activity Overview
    6 month trend
    373Downloads
    6 month trend
    283Hits

    Additional statistics for this dataset are available via IRStats2.

    Altmetric

    Repository staff only

    Edit record Edit record